Modulation of mast cell proteinase-activated receptor expression and IL-4 release by IL-12

Immunology and Cell Biology

Volumn 85, Issue 7, 2007, Pages 558-566

  Zhang, Huiyun ^a   Yang, Xiaoyu ^a   Yang, Haiwei ^a,b   Zhang, Zhongfang ^a   Lin, Qing ^a   Zheng, Yanshan ^a   Chen, Shaoying ^a   Yang, Pingchang ^c   He, Shaoheng ^a,b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

IL 12; IL 4; Mast cell; Protease activated receptor; Trypsin; Tryptase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; TRYPSIN; TRYPTASE;

ARTICLE; CYTOKINE RELEASE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAST CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

ANIMALS; BUTADIENES; CELLS, CULTURED; CHROMONES; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION REGULATION; IMIDAZOLES; INTERLEUKIN-12; INTERLEUKIN-4; MAST CELLS; MICE; MORPHOLINES; NITRILES; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; RECEPTORS, PROTEINASE-ACTIVATED; RNA, MESSENGER; TRYPSIN; TRYPTASES; TYRPHOSTINS;

EID: 34948866777     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100085     Document Type: Article

References (41)

1. Xie H, He SH. Roles of histamine and its receptors in allergic and inflammatory bowel diseases. World J Gastroenterol 2005; 11: 2851-2857.
2. He SH, Aslam A, Gaca MD, He Y, Buckley MG, Hollenberg MD et al. Inhibitors of tryptase as mast cell-stabilizing agents in the human airway: effects of trypatse and other agonists of proteinase-activated receptor 2 on histamine release. J Pharmacol Exp Ther 2004; 309: 119-126.
3. He S, Gaca MDA, Walls AF. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther 1998; 286: 289-297.
4. He S, Peng Q, Walls AF. Potent induction of neutrophil- and eosinophil rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol 1997; 159: 6216-6225.
5. Kinoshita M, Okada M, Hara M, Furukawa Y, Matsumori A. Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells. Arterioscler Thromb Vasc Biol 2005; 25: 1858-1863.
6. He SH, Xie H, Fu YL. Activation of human tonsil and skin mast cells by agonists of proteinase activated receptor-2. Acta Pharmacol Sin 2005; 26: 568-574.
7. Asokananthan N, Graham PT, Fink J, Knight DA, Bakker AJ, McWilliam AS et al. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 2002; 168: 3577-3585.
8. Li T, He S. Induction of IL-6 release from human T cells by PAR-1 and PAR-2 agonists. Immunol Cell Biol 2006; 84: 461-466.
9. Li T, Wang H, He S. Induction of interleukin-6 release from monocytes by serine proteinases and its potential mechanisms. Scand J Immunol 2006; 64: 10-16.
10. Wang H, He S. Induction of lactoferrin and IL-8 release from human neutrophils by tryptic enzymes via proteinase activated receptor-2. Cell Biol Int 2006; 30: 688-697.
11. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068.
12. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997; 272: 4043-4049.
13. Uehara A, Muramoto K, Takada H, Sugawara S. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 2003; 170: 5690-5696.
14. Schmidt VA, Nierman WC, Maglott DR, Cupit LD, Moskowitz KA, Wainer JA et al. The human proteinase-activated receptor-3 (PAR-3) gene: identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets. J Biol Chem 1998; 273: 15061-15068.
15. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6646.
16. Hirano K, Yufu H, Hirano M, Nishimura J, Kanaide H. Physiology and pathophysiology of proteinase-activated receptors (PARs):regulation of the expression of PARs. J Phamacol Sci 2005; 97: 31-37.
17. Knight DA, Lim S, Scaffidi AK, Roche N, Chung KF, Stewart GA et al. Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 2001; 108: 797-803.
18. Lan RS, Stewart GA, Goldie RG, Henry PJ. Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice. Am J Physiol 2004; 286: L388-L398.
19. Rohatgi T, Henrich-Noack P, Sedehizade F, Goertler M, Wallesch CW, Reymann KG et al. Transient focal ischemia in rat brain differentially regulates mRNA expression of proteaseactivated receptors 1 to 4. J Neurosci Res 2004; 75: 273-279.
20. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176: 1381-1386.
21. Kopf M, Le Gros G, Bachmann M, Lamers C, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362: 245-248.
22. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik E, Paul WE. B-cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated β-cells. J Immunol 1986; 136: 4538.
23. Gauldie J, Richards C, Harnish D, Lansdrop P, Baumann H. Interfero β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84: 7251-7255.
24. Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Mediators Inflamm 2001; 10: 51-59.
25. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003; 14: 361-368.
26. Tang C, Ward C, Reid D, Bish R, O'byrne PM, Walters EH. Normally suppressing CD40 coregulatory signals delivered by airway macrophages to TH2 lymphocytes are defective in patients with atopic asthma. J Allergy Clin Immunol 2001; 107: 863-870.
27. D'Andrea MR, Rogahn CJ, Andrade-Gordon P. Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade. Biotech Histochem 2000; 75: 85-90.
28. Colognato R, Slupsky JR, Jendrach M, Burysek L, Syrovets T, Simmet T. Differential expression and regulation of proteaseactivated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 2003; 102: 2645-2652.
29. Xiang Y, Masuko-Hongo K, Sekine T, Nakamura H, Yudoh K, Nishioka K et al. Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1beta, TNF-alpha and TGF-beta. Osteoarthr Cartil 2006; 14: 1163-1173.
30. Terada M, Kelly EA, Jarjour NN. Increased thrombin activity after allergen challenge: a potential link to airway remodeling? Am J Respir Crit Care Med 2004; 169: 373-377.
31. Hamilton JR, Frauman AG, Cocks TM. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium dependent relaxations to PAR2 and PAR4 agonists. Circ Res 2001; 89: 92-98.
32. Yan W, Tiruppathi C, Qiao R, Lum H, Malik AB. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J Cell Physiol 1996; 166: 561-567.
33. Shinohara T, Suzuki K, Takada K, Okada M, Ohsuzu F. Regulation of proteinase-activated receptor 1 by inflammatory mediators in human vascular endothelial cells. Cytokine 2002; 19: 66-75.
34. Mbebi C, Rohn T, Doyennette MA, Chevessier F, Jandrot-Perrus M, Hantai D et al. Thrombin receptor induction by injury-related factors in human skeletal muscle cells. Exp Cell Res 2001; 263: 77-87.
35. Schini-Kerth VB, Bassus S, Fisslthaler B, Kirchmaier CM, Busse R. Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta1 and platelet-derived growth factor AB. Circulation 1997; 96: 3888-3896.
36. Kriegel MA, Tretter T, Blank N, Schiller M, Gabler C, Winkler S et al. Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells. Immunology 2006; 119: 43-53.
37. Lorentz A, Wilke M, Sellge G, Worthmann H, Klempnauer J, Manns MP et al. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 2005; 174: 6751-6756.
38. Ammit AJ, Moir LM, Oliver B, Hughes JM, Alkhouri H, Ge Q et al. The effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007; 292: L199-L206.
39. Temkin V, Pickholtz D, Levi-Schaffer F. Tumor necrosis factors in a murine model of allergic peritonitis: effects on eosinophil accumulation and inflammatory mediators' release. Cytokine 2003; 24: 74-80.
40. Venkatesha RT, Berla Thangam E, Zaidi AK, Ali H. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 2005; 42: 581-587.
41. Jin A, Kurosu T, Tsuji K, Mizuchi D, Arai A, Fujita H et al. Miura OBCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion. Oncogene 2006; 25: 4332-4340.